Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers.
Nature Communications
Shah, Jennifer B JB; Pueschl, Dana D; Wubbenhorst, Bradley B; Fan, Mengyao M; Pluta, John J; D'Andrea, Kurt K; Hubert, Anna P AP; Shilan, Jake S JS; Zhou, Wenting W; Kraya, Adam A AA; Llop Guevara, Alba A; Ruan, Catherine C; Serra, Violeta V; BalmaƱa, Judith J; Feldman, Michael M; Morin, Pat J PJ; Nayak, Anupma A; Maxwell, Kara N KN; Domchek, Susan M SM; Nathanson, Katherine L KL
Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.
Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response.
British Journal Of Cancer
Gwili, Noha N; Jones, Stacey J SJ; Amri, Waleed Al WA; Carr, Ian M IM; Harris, Sarah S; Hogan, Brian V BV; Hughes, William E WE; Kim, Baek B; Langlands, Fiona E FE; Millican-Slater, Rebecca A RA; Pramanik, Arindam A; Thorne, James L JL; Verghese, Eldo T ET; Wells, Geoff G; Hamza, Mervat M; Younis, Layla L; El Deeb, Nevine M F NMF; Hughes, Thomas A TA
Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response.
British Journal Of Cancer
Gwili, Noha N; Jones, Stacey J SJ; Amri, Waleed Al WA; Carr, Ian M IM; Harris, Sarah S; Hogan, Brian V BV; Hughes, William E WE; Kim, Baek B; Langlands, Fiona E FE; Millican-Slater, Rebecca A RA; Pramanik, Arindam A; Thorne, James L JL; Verghese, Eldo T ET; Wells, Geoff G; Hamza, Mervat M; Younis, Layla L; El Deeb, Nevine M F NMF; Hughes, Thomas A TA